Mediclinic International plc

OTCPK:ANHG.Y Stock Report

Market Cap: US$4.1b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mediclinic International Management

Management criteria checks 4/4

Key information

Ronnie van der Merwe

Chief executive officer

UK£1.5m

Total compensation

CEO salary percentage37.5%
CEO tenure4.3yrs
CEO ownership0.009%
Management average tenure6.7yrs
Board average tenure4.3yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Ronnie van der Merwe's remuneration changed compared to Mediclinic International's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2022UK£2mUK£569k

UK£151m

Dec 31 2021n/an/a

UK£135m

Sep 30 2021n/an/a

UK£118m

Jun 30 2021n/an/a

UK£93m

Mar 31 2021UK£1mUK£434k

UK£68m

Dec 31 2020n/an/a

-UK£173m

Sep 30 2020n/an/a

-UK£414m

Jun 30 2020n/an/a

-UK£367m

Mar 31 2020UK£739kUK£543k

-UK£320m

Dec 31 2019n/an/a

-UK£97m

Sep 30 2019n/an/a

UK£126m

Jun 30 2019n/an/a

-UK£12m

Mar 31 2019UK£689kUK£447k

-UK£151m

Compensation vs Market: Ronnie's total compensation ($USD1.70M) is below average for companies of similar size in the US market ($USD6.83M).

Compensation vs Earnings: Ronnie's compensation has been consistent with company performance over the past year.

CEO

Ronnie van der Merwe (59 yo)

4.3yrs

Tenure

UK£1,519,000

Compensation

Dr. Carel Aron van der Merwe, also known as Ronnie, has been Executive Director of Mediclinic International plc since June 1, 2018. Dr. van der Merwe serves as Group Chief Executive Officer of Mediclinic I...

Leadership Team

NamePositionTenureCompensationOwnership
Carel van der Merwe
Group CEO & Executive Director4.3yrsUK£1.52m0.0090%
$ 367.2k
Petrus Myburgh
Group CFO & Executive Director6.2yrsUK£1.00m0.013%
$ 538.0k
Koert H. Pretorius
Group Chief Operating Officer15.9yrsUK£339.18kno data
Dirk Le Roux
Group Chief Information Officer8.2yrsUK£132.90kno data
James Arnold
Head of Investor Relationsno datano datano data
Gert Hattingh
Group Chief Governance Officer6.7yrsUK£239.51kno data
Biren Valodia
Chief Marketing Officer of Medi-Clinic Southern Africa no datano datano data
Clara Findlay
Chief Legal Officer of Medicalinic Southern Africano datano datano data
Wimpie Aucamp
Chief Operating Officer of Medi-Clinic for Southern Africano datano datano data
David Hadley
Chief Executive Officer of Medicalinic Middle East13.8yrsUK£425.82kno data
Daniel Liedtke
Chief Executive Officer of Hirslanden3.8yrsno datano data
Greg Wyk
CEO & Chief Human Resources Officer of Medicalinic Southern Africano datano datano data

6.7yrs

Average Tenure

57yo

Average Age

Experienced Management: ANHG.Y's management team is seasoned and experienced (6.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Carel van der Merwe
Group CEO & Executive Director4.3yrsUK£1.52m0.0090%
$ 367.2k
Petrus Myburgh
Group CFO & Executive Director6.2yrsUK£1.00m0.013%
$ 538.0k
Thomas Singer
Independent Non-Executive Director3.3yrsUK£90.000.0027%
$ 110.4k
Daniel Meintjes
Non-Executive Director26.8yrsUK£74.000.017%
$ 685.1k
Jan Durand
Non-Executive Director10.8yrsUK£80.00no data
Muhadditha Al-Hashimi
Independent Non-Executive Director4.9yrsUK£77.00no data
Inga Beale
Independent Non-Executive Chairman2.6yrsUK£280.00no data
Zarina Bibi Bassa
Independent Non-Executive Directorless than a yearUK£12.00no data
Felicity A. Harvey
Senior Independent Director5yrsUK£92.00no data
Steve Weiner
Independent Non-Executive Director2.3yrsUK£94.00no data
Anja Oswald
Independent Non-Executive Director4.3yrsUK£78.00no data
Natalia Barsegiyan
Independent Non-Executive Director1.2yrsUK£53.00no data

4.3yrs

Average Tenure

59yo

Average Age

Experienced Board: ANHG.Y's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/10/23 15:21
End of Day Share Price 2022/07/26 00:00
Earnings2022/03/31
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mediclinic International plc is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sean UngererArqaam Capital Research Offshore S.A.L.
Simon MatherBarclays
Victoria LambertBerenberg